Thomas Hartung

Bloomberg School of Public Health

Professor of pharmacology and toxicology at University of Konstanz, Germany, Director of CAAT (Center for Alternatives to Animal Testing) Johns Hopkins Univ., Bloomberg School of Public Health, Baltimore, USA

Specialty Chief Editor, Frontiers in Artificial Intelligence, Medicine and Public Health

Prof. Hartung and his team have developed computational models that apply Artificial Intelligence and machine-learning to the vast amounts of data that exist in toxicological databases to predict the toxicity of chemical. More specifically, in the context of developing drugs and vaccines against COVID-19, artificial intelligence & in vitro / in silico models—high-throughput screening methods do have a crucial role to play. His work aims to provide a better, safer, more humane future for people and animals.